SCFAs involve glucose metabolism, insulin sensitivity, and lipogenesis through diverse pathways, thereby affecting the development of diabetes, obesity, and NAFLD [15,16]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.